SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Current Liabilities | ₹374 Cr | ₹265 Cr | ₹179 Cr |
What is the latest Total Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹374 Cr |
| Mar2024 | ₹265 Cr |
| Mar2023 | ₹179 Cr |
How is Total Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹374 Cr | 41.19 | |
| Mar2024 | ₹265 Cr | 48.12 | |
| Mar2023 | ₹179 Cr | - | |
Compare Total Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,025.4 Cr | -3.2% | -11.1% | 1.6% | Stock Analytics | |
| SAGILITY INDIA | ₹18,617.6 Cr | -1.6% | -20.1% | -4% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,260.6 Cr | -5.2% | -15.5% | -40.9% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹6,458.1 Cr | -6.5% | -33.7% | -16.8% | Stock Analytics | |
| JUST DIAL | ₹4,546.1 Cr | -7.6% | -18.7% | -41.1% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹1,884.0 Cr | -11.5% | -31.2% | -59.4% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -3.2% |
-11.1% |
1.6% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses